AtriCure, Inc. (ATRC) Reports Q4 Loss of $0.13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $60.41 +0.89%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
FUSE, INM, TRI, More
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $17.16 million.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- First Tracks Biotherapeutics, Inc. (TRAX) Misses Q3 EPS by 88c
- LATAM Airlines (LTM) Misses Q3 EPS by 135c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
